![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Mihara, Ryosuke; Kabashima, Kenji; Furue, Masutaka; Nakano, Miwa und Ruzicka, Thomas
(2019):
Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study.
In: Journal of Dermatology, Bd. 46, Nr. 8: S. 662-671
Kabashima, Kenji; Furue, Masutaka; Hanifin, Jon M.; Pulka, Grazyna; Wollenberg, Andreas; Galus, Ryszard; Etoh, Takafumi; Mihara, Ryosuke; Nakano, Miwa und Ruzicka, Thomas
(2018):
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study.
In: Journal of Allergy and Clinical Immunology, Bd. 142, Nr. 4: S. 1121-1130
Ruzicka, Thomas; Hanifin, Jon M.; Furue, Masutaka; Pulka, Grazyna; Mlynarczyk, Izabela; Wollenberg, Andreas; Galus, Ryszard; Etoh, Takafumi; Mihara, Ryosuke; Yoshida, Hiroki; Stewart, Jonathan und Kabashima, Kenji
(2017):
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
In: New England Journal of Medicine, Bd. 376, Nr. 9: S. 826-835
Ruzicka, Thomas und Mihara, Ryosuke
(2017):
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis REPLY.
In: New England Journal of Medicine, Bd. 376, Nr. 21: S. 2093